Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Differentiation Induction in Acute Myelogenous Leukemia
This study is ongoing, but not recruiting participants.
Study NCT00175812 Information provided by University of Bergen
First Received: September 9, 2005 Last Updated: February 27, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Acute Myelogenous Leukemia
Additional conditions recognized in this trial
Leukemia
Leukemia, Myeloid
Leukemia, Myeloid, Acute
More general conditions related to this trial
Neoplasms
Neoplasms by Histologic Type
Interventions listed in this trial
all-trans retinoic acid (ATRA)
Valproic acid
Theophyllin
Additional drug interventions recognized in this trial
Theophylline
Tretinoin
More general drug interventions related to this trial
Anti-Asthmatic Agents
Anticonvulsants
Antimanic Agents
Antineoplastic Agents
Autonomic Agents
Bronchodilator Agents
Cardiovascular Agents
Central Nervous System Agents
Central Nervous System Depressants
Dermatologic Agents
Enzyme Inhibitors
GABA Agents
Keratolytic Agents
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Phosphodiesterase Inhibitors
Physiological Effects of Drugs
Psychotropic Drugs
Respiratory System Agents
Therapeutic Uses
Tranquilizing Agents
Vasodilator Agents
Sponsors listed in this trial
University of Bergen
Back to top of Main Content
